JP5249484B2 - 医薬組成物 - Google Patents

医薬組成物 Download PDF

Info

Publication number
JP5249484B2
JP5249484B2 JP2002356114A JP2002356114A JP5249484B2 JP 5249484 B2 JP5249484 B2 JP 5249484B2 JP 2002356114 A JP2002356114 A JP 2002356114A JP 2002356114 A JP2002356114 A JP 2002356114A JP 5249484 B2 JP5249484 B2 JP 5249484B2
Authority
JP
Japan
Prior art keywords
compound
methyl
acid
phenoxy
benzimidazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2002356114A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003238406A (ja
JP2003238406A5 (enExample
Inventor
智之 柴田
慎一 蔵方
尚美 島崎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Sankyo Co Ltd
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Priority to JP2002356114A priority Critical patent/JP5249484B2/ja
Publication of JP2003238406A publication Critical patent/JP2003238406A/ja
Publication of JP2003238406A5 publication Critical patent/JP2003238406A5/ja
Application granted granted Critical
Publication of JP5249484B2 publication Critical patent/JP5249484B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2002356114A 2001-12-11 2002-12-09 医薬組成物 Expired - Fee Related JP5249484B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002356114A JP5249484B2 (ja) 2001-12-11 2002-12-09 医薬組成物

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2001-376954 2001-12-11
JP2001376954 2001-12-11
JP2001376954 2001-12-11
JP2002356114A JP5249484B2 (ja) 2001-12-11 2002-12-09 医薬組成物

Publications (3)

Publication Number Publication Date
JP2003238406A JP2003238406A (ja) 2003-08-27
JP2003238406A5 JP2003238406A5 (enExample) 2006-03-30
JP5249484B2 true JP5249484B2 (ja) 2013-07-31

Family

ID=27790693

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002356114A Expired - Fee Related JP5249484B2 (ja) 2001-12-11 2002-12-09 医薬組成物

Country Status (1)

Country Link
JP (1) JP5249484B2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101068770B (zh) 2004-09-28 2012-01-04 三共株式会社 制备6-取代的-1-甲基-1-h-苯并咪唑衍生物的方法及其合成中间体
JP4789180B2 (ja) * 2004-09-28 2011-10-12 第一三共株式会社 ６−置換−１−メチル−１−ｈ−ベンズイミダゾール誘導体の製造方法及びその製造中間体
WO2007091622A1 (ja) * 2006-02-09 2007-08-16 Daiichi Sankyo Company, Limited 抗癌医薬組成物
TW200838512A (en) * 2007-02-08 2008-10-01 Daiichi Sankyo Co Ltd Crystalline forms of a thiazolidinedione compound and manufacturing methods thereof
JPWO2010013768A1 (ja) * 2008-07-31 2012-01-12 第一三共株式会社 チアゾリジンジオン化合物の結晶及びその製造方法
US20110160462A1 (en) 2008-07-31 2011-06-30 Daiichi Sankyo Company, Limited Crystalline forms of thiazolidinedione compound and its manufacturing method

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ282548B6 (cs) * 1992-01-22 1997-08-13 F. Hoffmann-La Roche Ag Farmaceutický přípravek
AU5664294A (en) * 1993-01-11 1995-02-28 Ligand Pharmaceuticals, Inc. Compounds having selective activity for retinoid x receptors, and means for modulation of processes mediated by retinoid x receptors
MX9306629A (es) * 1993-01-11 1994-07-29 Ligand Pharm Inc Compuestos que tienen actividad selectiva para receptores retinoide x, medios para modulacion de procesos mediados pr receptores de retinoide x.
BR9610875A (pt) * 1995-10-06 1999-07-13 Ligand Pharm Inc Modulares rxr seletivos - dimeros e processos para seu uso
EP0948324B1 (en) * 1996-12-11 2003-11-12 Dana-Farber Cancer Institute, Inc. Methods and pharmaceutical compositions for inhibiting tumour cell growth comprising a ppar-gamma agonist and a map kinase inhibitor
AU5811298A (en) * 1996-12-31 1998-07-31 Salk Institute For Biological Studies, The Treatment of disease states which result from neoplastic cell proliferation using ppar-gamma activators and compositions useful therefor
PL334840A1 (en) * 1997-01-24 2000-03-27 Univ California Application of fxr, pparalpha and lxralpha activators in order to restore the barrier function, to stimulate epithelium differentation and to inhibit proliferation
JP3488099B2 (ja) * 1997-10-08 2004-01-19 三共株式会社 置換縮合複素環化合物
KR20020010581A (ko) * 1999-03-11 2002-02-04 사단호진 산교 소죠켄큐쇼 핵수용체 ｐｐａｒ의 신규한 리간드
JP4169450B2 (ja) * 1999-04-07 2008-10-22 第一三共株式会社 インスリン抵抗性改善剤
JP4197387B2 (ja) * 1999-04-07 2008-12-17 第一三共株式会社 アミン誘導体化合物
CA2369910A1 (en) * 1999-04-23 2000-11-02 Bristol-Myers Squibb Company Compositions and methods for treatment of hyperproliferative diseases

Also Published As

Publication number Publication date
JP2003238406A (ja) 2003-08-27

Similar Documents

Publication Publication Date Title
US8987461B2 (en) Histone demethylase inhibitors
US9023882B2 (en) 5-membered nitrogen containing heterocyclic derivatives and pharmaceutical compositions comprising the same
WO1992009279A1 (fr) Derive de 2-arylthiazole et composition pharmaceutique contenant ce derive
KR20140041583A (ko) Ｌｒｒｋ2 키나제 활성의 억제제
GB2210368A (en) 2-aryl substituted heterocyclic compounds as antiallergic and anti-inflammatory agents
HUT76637A (en) Bezoxazoles and pyridine derivatives, pharmaceutical compositions containing them, process for producing them and their use and the intermediates of the compounds
JP2007015928A (ja) 新規オレフィン誘導体
WO2005105763A1 (en) Substituted morpholine compounds for the treatment of central nervous system disorders
EP4380928B1 (en) Pparg inverse agonists and uses thereof
JP2020509062A (ja) ２−（置換フェニルヘテロ）芳香族カルボン酸系ｆｔｏ阻害剤、その製造方法およびその使用
JPWO2002076918A1 (ja) 置換安息香酸誘導体を有効成分とするＮＦ−κＢ阻害剤
WO2019196714A1 (zh) 作为dhodh抑制剂的n-取代丙烯酰胺衍生物及其制备和用途
US8263622B2 (en) Fused-ring derivative and medical application of same
EP2505198A1 (en) Compounds for use as therapeutic agents affecting p53 expression and/or activity
JP5249484B2 (ja) 医薬組成物
Munikrishnappa et al. Design, synthesis, and biological evaluation of novel bromo-pyrimidine analogues as tyrosine kinase inhibitors
WO2008087514A2 (en) Hdac inhibitors
US7759350B2 (en) Pyrimidine carboxamides
CN101243073A (zh) 5－ht1a受体的哌嗪－哌啶拮抗剂与激动剂
WO2008025526A1 (en) Indole derivatives, their manufacture and use as pharmaceutical agents
KR102002446B1 (ko) TGase 2 억제제로서의 퀴놀린-5,8-디온 유도체 및 이를 포함하는 약제학적 조성물
US8263044B2 (en) Stilbene like compounds as novel HDAC inhibitors
JP6758374B2 (ja) Ｉｄｈ２突然変異を標的とする抗腫瘍化合物及びその使用方法
WO2006070878A1 (ja) カルボン酸誘導体またはその塩
JP2017206444A (ja) 置換フェニル化合物

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20040816

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20050517

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20050602

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051209

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060210

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090728

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090918

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20090918

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100305

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100422

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100901

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130412

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160419

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees